INTRODUCTION
Insulin-like growth factor receptor (IGF-1R) is a key point of convergence for major signaling pathways implicated in human physiology and pathophysiology. Clinical evidence has indicated that IGF-1R has potent antiapoptotic and transforming activities and that increased IGF-1R is associated with cell survival and proliferation, cancer progression, metastasis, treatment resistance, and poor prognosis. 1, 2 Preclinical studies have demonstrated that activated IGF-1R could mediate tumorigenesis, mainly through two major downstream signaling pathways: phosphatidylinositol-3-kinase (PI3K)-Akt and Ras-mitogen-activated protein kinase (Ras-MAPK) pathways. [3] [4] [5] Rationally, targeting IGF-1R could serve as a promising approach in anticancer therapeutics. 6, 7 To date, over 10 IGF-1R-targeted drugs, including small-molecule drugs and anti-IGF-1R antibodies, have been approved for clinical trials. 8, 9 Other strategies targeting IGF-1R by small nucleotides complementary to IGF-1R have also been tested in experimental therapeutics. 10 However, despite some initial promising preclinical results, the clinical disclosures subsequently have been less encouraging. Moreover, recent studies revealed that IGF-1R participates in a dynamic and complex signaling network, interacting with additional targets and pathways thereof through various crosstalk and compensatory signaling mechanisms. 11 Further understanding of such mechanisms around IGF-1R, especially its interactions with other signaling pathways, could help us to shed some light on the decreased effectiveness of selective IGF-1R-targeted therapies. We anticipate that targeting these bypass signaling pathways of IGF-1R might produce a more effective therapeutic response in cancers.
Melanoma differentiation-associated gene 5 (MDA5) helicases and retinoic acid-inducible gene-I (RIG-I), two so-called RIG-I-like receptor (RLR) family proteins, have been known as sensors of double-stranded RNA (dsRNA) responsible for the induction of type I interferon (IFN). 12, 13 In infected cells, MDA5 and RIG-I have distinct biological roles in the specificity of virus recognition as well as RNAbinding specificity: RIG-I recognizes short dsRNA and 5 0 triphosphate single-stranded (ss)RNA, while MDA5 senses long dsRNA.
14 LGP2
(laboratory of genetics and physiology 2) is the third RNA helicase comprising the RIG-I-like helicase (RLH) family of receptors for detecting RNA viruses. 15, 16 Polyinosinic-polycytidylic acid (poly(I:C)), a synthetic mimic of long dsRNA, has been identified as a strong activator of MDA5. 17 Viral RNA mimetic synthetic 5ʹ-triphosphate RNA (pppRNA) recognizes RIG-I. 18 Upon RNA viruses, RIG-I and MDA5
recognize viral nucleic acids and proteins, and they bind to the adaptor protein IFN-b promoter stimulator 1 (IPS-1), which is tethered to the outer mitochondrial membrane. 19 This reciprocal interaction triggers a complex signal transduction cascade culminating in the activation of transcription factors (particularly nuclear factor kB [NF-kB] and IFN regulatory factor 3 ) and the production of cytokines, including type I IFN. 20 Interestingly, Besch et al. 21 uncovered an IFN-independent antiviral signaling pathway initiated by RIG-I and MDA5 that could activate proapoptotic signaling in human melanoma cells through the introduction of pppRNA or poly(I:C), a synthetic mimic of long dsRNA. The RIG-I-and MDA5-initiated proapoptotic pathway is more active in melanoma cells than nonmalignant cells, and thereby RIG-I-and MDA5-mediated apoptosis results in preferential tumor cell death. Due to their immunostimulatory and proapoptotic activities, RIG-I and MDA5 ligands through intracellular delivery of viral RNA mimetics might be an optimal anticancer therapy. 21 Surprisingly, an unanticipated observation is that knockdown of IGF-1R could trigger cytoplasmic RNA sensors MDA5 and RIG-I as delivering poly(I:C) and pppRNA had. In our group, we had performed high-throughput sequencing (RNA sequencing) in human colonic cancer cells with knockdown of IGF-1R. The RNA sequencing data indicated a surprising result that there was a significant link between knockdown of IGF-1R and upregulations of viral RNA sensors MDA5 and RIG-I (all of these data are at GEO: GSE122534, https://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc=GSE122534). Our further in vivo and in vitro results revealed that the knockdown of IGF-1R triggered MDA5 and RIG-I expressions in human cancer cells as well as human nonmalignant cells. Using human colonic cancer cell lines and the azoxymethane (AOM)-dextran sulfate sodium (DSS) colorectal cancer model, we confirmed that knockdown of IGF-1R triggered mitochondrial apoptosis through the upregulations of MDA5 and RIG-I. Further, we showed that increased MDA5 and RIG-I mediated the mitochondrial apoptosis through initiating the proapoptotic BH3-only proteins Bim in cancer cells. Due to normal cells being less sensitive to this endogenous proapoptotic signaling than cancer cells, 21 IGF-1R knockdown-triggered MDA5-and RIG-I-mediated apoptosis could lead to preferential tumor cell death. These findings suggest that targeting IGF-1R to trigger MDA5 and RIG-I might have therapeutic potential for cancer treatment. In addition, IGF-1R knockdown also triggers MDA5 and RIG-I in human normal colonic epithelial cells. This finding provides us some clues in antivirus research that targeting IGF-1R might play roles in infected cells against the virus through triggering MDA5 and RIG-I. Figure 4B ). These findings in human normal cells provide us some clues in antivirus research that the downregulation of IGF-1R might play roles in infected cells against the virus through triggering MDA5 and RIG-I. Furthermore, we compared the increased levels of MDA5 and RIG-I in these cancer cell lines and human normal epithelial cells. Cancer cells had higher responses to the knockdown of IGF-1R than did normal cells in triggering MDA5 and RIG-I ( Figure 4C ).
RESULTS

Heterozygous
Knockdown of IGF-1R Triggered MDA5-and RIG-I-Mediated Mitochondrial Apoptosis in Human Colonic Cancer Cells
Previous study showed that poly(I:C) and pppRNA increased cytoplasmic MDA5 and RIG-I, thereby leading to mitochondrial apoptosis independently of type I IFN in human melanoma cells. 21, 23 In our study, an unanticipated observation was that IGF-1R knockdown triggered cytoplasmic MDA5-and RIG-I-mediated mitochondrial apoptosis in cancer cells, as poly(I:C) had ( Figure 5A ). Knockdown of IGF-1R-triggered MDA5 and RIG-I consequently reduced cell survival, since IGF-1R activation by the addition of IGF-1 strongly increased cell survival ( Figure 5B, a) . Poly(I:C) dose-dependently decreased the survival of HT-29 cells through the activation of MDA5-mediated apoptosis. Similarly, 50 mM siIGF-1R treatment in HT-29 cells achieved the same efficacy as poly(I:C) had ( Figure 5B, b) .
To investigate apoptotic signaling triggered by MDA5 and RIG-I, we analyzed the levels of mitochondrial membrane potential (MMP). Loss of MMP leads to the release of cytochrome c, initiating a caspase www.moleculartherapy.org cascade in the mitochondrial apoptosis pathway. 24 Fluorescent 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-imidacarbocyanine iodide (JC-1) probe analysis showed a loss of MMP in HT-29 cancer cells transfected with siIGF-1R, showing a significant increase in green fluorescence ( Figure 5C , second row), which was similar to the apoptotic effect that poly(I:C) had ( Figure 5C , third row).
Western blotting assay showed an increase in cytochrome c and Bim in siIGF-1R-transfected cells (***p < 0.001 versus NC cells), and increased levels of these mitochondria-associated proteins were higher than those in poly(I:C)-treated cells (**p < 0.01) ( Figure 5D ). Neither silencing MDA5 nor activating IGF-1R by the addition of IGF-1 affected the expressions of cytochrome c and Bim. These results suggest that IGF-1R knockdown triggered MDA5-and RIG-I-mediated cancer cell apoptosis through the mitochondrial pathway. Figure 6B, middle) . Analysis of the tumor size distribution showed larger tumors in WT than Igf1r +/À mice. Larger-sized tumors (>5 mm) were frequently seen in WT, but not in Igf1r +/À , mice (Figure 6B, right) . Histopathological analyses showed advanced colonic adenocarcinoma in WT mice and only low-grade dysplastic mucosa in Igf1r +/À mice ( Figure 6C ). IHC assay showed a strong diffuse staining of Ki-67 and PCNA in cancer epithelium and high-grade dysplastic mucosa in WT mice, whereas it showed only scattered positivity in the basal cells of colorectal crypt and low-grade dysplastic mucosa in Igf1r +/À mice ( Figure 6D ). To investigate the association of IGF-1R knockdown-triggered MDA5 and RIG-I to the PI3K-Akt pathway, we compared the expression levels of MDA5 in the cell lines with high p-AKT induced by SC79 to the same cell lines without SC79. SC79 at 10 mM for 1.5 h significantly increased p-AKT in NCM460 cells and HCT-116, HT-29, and SW480 cell lines. At the same time, significant changes in MDA5 were not seen in both of these cell lines as compared to the cell lines without SC79 ( Figure 7A ). Significant changes in MDA5 were also not seen in the cell lines with knockdown AKT by 5 mM AKT inhibitor VIII ( Figure 7B ). On the other hand, we compared the expression levels of p-AKT in the cells with high MDA5 induced by poly(I:C) to the same cell lines without poly(I:C). There was no significant difference between the level of p-AKT in the cell lines treated with poly(I:C) and that of the cell lines without poly(I:C) treatment ( Figure 7C ). Downregulation of MDA5 by siMDA5 did not affect the expression of p-AKT ( Figure 7D ).
Knockdown of IGF-1R induced cancer apoptosis in
Further, Igf1r +/À mice exposed to AOM-DSS were treated with SC79 (0.04 mg/g, intraperitoneally [i.p.], for 2 weeks) for inducing p-AKT. A significant change in MDA5 was not seen in the intestinal epithelium as compared to the Igf1r +/À mice without SC79 ( Figure 7E ).
These results suggest that knockdown of IGF-1R-triggered MDA5 
DISCUSSION
IGF-1R signaling has long been recognized as a driver of tumorigenesis in multiple cancers. Classically, IGF-1R has mediated tumorigenesis through the activation of two well-established oncogenic pathways: the PI3K-Akt pathway and the Ras-MAPK pathway. [26] [27] [28] [29] From then on, multiple approaches have been undertaken to modulate IGF-1R activity for the aim of anticancer therapeutics. However, most clinical disclosures have been less encouraging, probably due to the complex signaling network of IGF-1R as a key convergence in physiology. A greater understanding of cancer biology around IGF-1R has thus remained necessary for investigating an effective therapeutic response through targeting IGF-1R.
In our group, the high-throughput sequencing data in human colonic cancer cells gave us a surprising result that there is a significant link between knockdown IGF-1R and increased RNA sensors MDA5 and RIG-I. The following in vivo and in vitro experiments confirmed that knockdown IGF-1R triggers MDA5-and RIG-I-mediated mitochondrial apoptosis, leading to the inhibition of colorectal cancer. Although the proapoptotic signaling pathway is also active in nonmalignant cells, these nonmalignant cells were much less sensitive to apoptosis than cancer cells. 21, 23 Further, endogenous Bcl-xL could rescue nonmalignant, but not cancer, cells from MDA5-and RIG-I-mediated mitochondrial apoptosis. 23 Knockdown IGF-1R-triggered MDA5 and RIG-I might preferentially mediate apoptosis in cancer cells. Previously, Besch et al. 21 showed that ligation of MDA5 and RIG-I by RNA mimetics poly(I:C) and pppRNA could trigger the mitochondrial apoptosis in human melanoma cells in an IFN-independent fashion. They suggested that tumor cell killing and immunostimulation could synergize for optimal anticancer immunochemotherapy. 21 In our study, the in vitro and in vivo results showed the upregulation of MDA5 in human cancer cells as well as human normal cells through the knockdown of IGF-1R, as poly(I:C) had.
Viral RNA sensors MDA5 and RIG-I belong to the DExD/H box RNA helicase family. The classical model described in the mitochondrial antiviral signaling is that RNA virus is recognized by RIG-I and MDA5 in the cytoplasm. Due to RIG-I and MDA5 containing two N-terminal caspase recruitment domains (CARDs) for relaying signal downstream, N-terminal CARDs of RIG-I and MDA5 could trigger the intracellular signaling pathways via IPS-1, which is tethered to the outer mitochondrial membrane. This interaction then could trigger a complex signal transduction cascade, culminating in the activation of transcription factors (in particular, NF-kB and IRF-3) and the production of cytokines, including class I IFNs. 21, 23, 30 Interestingly, Besch's study 21 showed that ligation of viral RNA sensors RIG-I and MDA5 by delivering poly(I:C) initiated a proapoptotic signaling pathway that was independent of type I IFNs in human melanoma cells. Delivery of viral RNA mimetic might be an optimal anticancer therapy.
23 Surprisingly, our study demonstrated that the knockdown of IGF-1R could trigger viral RNA sensors MDA5 and RIG-I as poly(I:C) and pppRNA had. IGF-1R knockdown-triggered MDA5 and RIG-I also mediated the IFN-independent mitochondrial apoptosis as poly(I:C) and pppRNA had. Our results further showed that the activation of RIG-I and MDA5 by IGF-1R knockdown could dramatically increase the expression of proapoptotic BH3-only protein Bim; the apoptosomes cytochrome c, Apaf-1, and caspase-9; and the critical executioner of mitochondrial apoptosis caspase-3, thereby leading to a strong inhibition of cancer growth in Igf1r +/À mice. We thus suggest that IGF-1R knockdown-triggered MDA5 and RIG-I mediated the apoptosis of cancer cells through the mitochondrial pathway.
More surprisingly, knockdown IGF-1R also triggered MDA5 and RIG-I expressions in human nonmalignant cells. Because nonmalignant cells exhibited lower levels of MDA5 and RIG-I than cancer cells, IGF-1R knockdown-triggered MDA5-and RIG-I-mediated apoptosis might lead to preferential tumor cell death. Our further in vitro and in vivo studies revealed that IGF-1R knockdown-triggered MDA5 and RIG-I was independent of the PI3K-Akt pathway. We thus suggest a new signal transduction pathway of IGF-1R in colonic tumorigenesis. Knockdown of IGF-1R-induced mitochondrial apoptosis in colonic cancer cells is mediated by upregulations of MDA5 and RIG-I. Targeting IGF-1R to trigger MDA5 and RIG-I might have therapeutic potential for cancer treatment. In addition, the upregulations of MDA5 and RIG-I in human normal cells provide us some clues in antivirus research that targeting IGF-1R might play roles in infected cells against the virus through triggering MDA5 and RIG-I. However, the mechanisms of IGF-1R knockdown-triggered MDA5 and RIG-I still have to be uncovered. The project of investigating the signaling pathways between IGF-1R and MDA5 and RIG-I is currently underway.
In conclusion, we have identified a new pathway of IGF-1R in its signal transduction such that knockdown of IGF-1R triggers viral RNA sensors MDA5 and RIG-I in both cancer cells and normal cells. IGF-1R knockdown-triggered MDA5 and RIG-I mediate mitochondrial apoptosis in cancer cells. We anticipate that targeting IGF-1R to trigger MDA5 and RIG-I might have therapeutic potential for cancer treatment. www.moleculartherapy.org
MATERIALS AND METHODS
Igf1r
+/-Mice and Care
The Committee on the Ethics of Animal Experiments of Capital Medical University approved the animal experiments and protocols (permit AEEI-2016-043). We inactivated the IGF-1R gene by homologous recombination by using the Cre-lox strategy to delete the essential exon 3 of gene, according to the reference. 22 Igf1r +/À mice were generated by Cyagen Biosciences (Guangzhou, China). Igf1r
+/À mice and their WT littermates were caged under a controlled room temperature, humidity, and light (12-h-light/12-h-dark cycle), and they were allowed unrestricted access to standard mouse chow, containing 52% carbohydrate, 12% fat, 23% protein, 4% fiber, 6% ash, and 3% moisture, and tap water. 31 
Mouse Colorectal Cancer Model
Igf1r +/À mice (both male and female, 6 weeks of age) were exposed to AOM-DSS for inducing colorectal cancer, as described. 25, 32 Mice were intraperitoneally injected with 10 mg/kg AOM (Sigma), followed by three rounds of oral 1.0% DSS (MP Biomedicals). Their WT littermates were also used for all the experiments to ensure the same genetic background. At 20 weeks of age, mice were sacrificed, and colorectal cancer was analyzed by counting tumors, histopathology, and IHC assays.
Histopathology, IHC Staining, and TUNEL Analysis
Routine H&E staining of 4-mm-thick sections of colorectal tissues was used for histological, IHC, and TUNEL analyses. IHC assay was performed using antibodies against MDA5 (ab79055, Abcam), RIG-I (ab45428, Abcam), IGF-1R (ab39398, Abcam), PCNA (ab29, Abcam), and Ki-67 (ab15580, Abcam). TUNEL assay was performed by using in situ cell death detection kit (Roche, Germany).
Cell Lines, Cell Culture, and Treatment
Human colonic cancer cell lines HT-29, SW480, and HCT-116 and human colonic epithelial cell line NCM460 were purchased from China Cell Bank (authorized by ATCC). Cells were grown in RPMI 1640 medium containing 10% fetal bovine serum at 37 C in a humid atmosphere (5% CO 2 ). Cells grown in 3.5-cm dishes were routinely transfected with siIGF-1R (5 Mouse colorectal tissues and human colonic cancer cells were routinely used to perform immunofluorescence analysis. The primary antibodies were anti-IGF-1R (ab39398, Abcam) and anti-MDA5 (ab79055, Abcam). After staining with Alexa488-labeled anti-rabbit (CA11008S, Invitrogen) or Alexa594-labeled chicken anti-goat (1387734, Invitrogen), cell nuclei were counterstained with DAPI (Sigma). Images were acquired under a confocal laser-imaging system (TCS SP8, Leica).
Annexin V-FITC-PI Staining Assay
Human colonic cancer cells were transfected with siIGF-1R, siMDA5, and poly(I:C), respectively, and their corresponding NC for 48 h. Cells were collected, and then we performed Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) staining assay by using a cell apoptosis detection kit (BD Biosciences). Apoptotic cells were estimated in a flow cytometer (BD Biosciences).
MMP Staining Analysis
Fluorescent probe JC-1 was used to determine MMP, which specifically to mitochondria is incorporated into the mitochondrial membrane. Human colonic cancer cells cultured in slides were stained with 5 mM JC-1 (Beyotime, China) in the dark at 37 C for 10 min and washed with PBS 3 times. Fluorescence was analyzed under a fluorescence microscope by using ImagePro Plus software.
Western Blotting Analysis
Western blotting assay was routinely performed by using antibodies , and SW480 were exposed to 10 mM SC79 for 1.5 h. SC79 increased the levels of p-AKT in these cell lines (*p < 0.05, **p < 0.01 between the cells without and with SC79). Significant changes of MDA5 were not seen in these cell lines as compared to the cell lines without SC79 (p < 0.05). (B) Cells were treated with AKT inhibitor VIII (5 mM) for 1.5 h and then the levels of p-AKT and MDA5 were determined. Levels of p-AKT were significantly reduced (*p < 0.05, **p < 0.01, ***p < 0.001 between the cells without and with AKT inhibitor VIII). Significant changes of MDA5 were not seen as compared to the cells without AKT inhibitor VIII (p < 0.05). (C) Cells were treated by poly(I:C) (200 ng/mL) for 24 h and then levels of MDA5 and p-AKT were analyzed. The level of MDA5 was increased by poly(I:C) (*p < 0.05, **p < 0.01 between the cells without and with poly(I:C)). Significant changes of p-AKT were not seen between the cells without and with poly(I:C) (p < 0.05). (D) Cells were treated by siMDA5 for 24 h and then the levels of p-AKT were determined (**p < 0.01, ***p < 0.001). There was no difference between levels of p-AKT expressed in the cell lines treated by poly(I:C) and that of the cell lines without poly(I:C) (p < 0.05). (E) Igf1r +/À mice and their WT littermates were exposed to AOM-DSS for inducing colorectal cancer. Mice were then treated with SC79 (0.04 mg/g, i.p.) for 2 weeks. Igf1r +/À mice exhibited lower p-AKT (***p < 0.001) and higher MDA5
(##p < 0.01) than those in WT mice (first and second rows). During tumorigenesis, AOM-DSS induced higher p-AKT in both Igf1r +/À mice and Igf1r +/À mice exposed to SC79 (**p < 0.01, ***p < 0.001 versus without AOM-DSS) and WT mice (**p < 0.01, ***p < 0.001 versus without AOM-DSS), among which WT mice exhibited the highest level of PCNA, following Igf1r +/À mice with SC79 and Igf1r +/À mice without SC79 (^^p < 0.01 versus WT). A significant difference of MDA5 was not seen in Igf1r +/À mice exposed to SC79 and without SC79 (p < 0.05).
www.moleculartherapy.org chemiluminescence (Millipore) and quantified by densitometry analyzed by using Alphaview software. Densitometric analyses of bands were normalized with b-actin functioning as a loading control.
Statistical Analysis
Data were described as mean ± SD. Statistical analysis was done with SPSS/Win19.0 software (SPSS, Chicago, IL). Comparison between Igf1r +/À and WT mice was conducted by two-tailed Student's t test. A p value less than 0.05 was considered statistically significant. 
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